Meilleure Health International Industry Group Limited released its monthly return for the period ended 31 August 2026, indicating no movements in either authorised or issued share capital during the month. All headline share metrics remained unchanged, and the company confirmed ongoing compliance with Hong Kong’s minimum public-float requirement.

Authorised Capital • The authorised share capital stayed at 10.00 billion ordinary shares with a par value of HKD 0.01 each, representing HKD 100.00 million in aggregate.

Issued and Treasury Shares • Issued shares (excluding treasury shares) remained at 4.06 billion. • Treasury shares totalled 5.33 million, unchanged from the prior month. • Consequently, total issued shares (including treasury holdings) stood at 4.06 billion.

Equity Incentive Schemes • 2019 Share Option Scheme: 16.97 million options were outstanding; no grants, exercises, cancellations or lapses occurred. The scheme still permits up to 427.18 million new shares to be issued. • 2026 Share Award Scheme: No awards vested or cancelled during August; up to 408.84 million shares remain available for future issuance. • No warrants, convertible securities or other equity-linked instruments were outstanding or exercised.

Capital-Raising and Treasury Activity • The company did not issue any new shares, transfer treasury shares, or raise funds during the month.

Public Float • Management confirmed that the public float exceeded the Main Board’s initial prescribed threshold of 25% of total issued shares (excluding treasury shares).

With all key share metrics flat in August 2026, Meilleure Health enters September maintaining stable capital structure and regulatory compliance.